Diseases, Free Full-Text

Por um escritor misterioso
Last updated 07 julho 2024
Diseases, Free Full-Text
(1) Introduction: Traumatic brain injury (TBI) is a leading cause of injury and mortality worldwide, carrying an estimated cost of $38 billion in the United States alone. Neutrophil to lymphocyte ratio (NLR) has been investigated as a standardized biomarker that can be used to predict outcomes of TBI. The aim of this review was to determine the prognostic utility of NLR among patients admitted for TBI. (2) Methods: A literature search was conducted in PubMed, Scopus, and Web of Science in November 2022 to retrieve articles regarding the use of neutrophil to lymphocyte ratio (NLR) as a prognostic measure in traumatic brain injury (TBI) patients. Inclusion criteria included studies reporting outcomes of TBI patients with associated NLR values. Exclusion criteria were studies reporting only non-primary data, those insufficiently disaggregated to extract NLR data, and non-English or cadaveric studies. The Newcastle-Ottawa Scale was utilized to assess for the presence of bias in included studies. (3) Results: Following the final study selection 19 articles were included for quantitative and qualitative analysis. The average age was 46.25 years. Of the 7750 patients, 73% were male. Average GCS at presentation was 10.51. There was no significant difference in the NLR between surgical vs. non-surgical cohorts (SMD 2.41 95% CI −1.82 to 6.63, p = 0.264). There was no significant difference in the NLR between bleeding vs. non-bleeding cohorts (SMD 4.84 95% CI −0.26 to 9.93, p = 0.0627). There was a significant increase in the NLR between favorable vs. non-favorable cohorts (SMD 1.31 95% CI 0.33 to 2.29, p = 0.0090). (4) Conclusions: Our study found that NLR was only significantly predictive for adverse outcomes in TBI patients and not surgical treatment or intracranial hemorrhage, making it nonetheless an affordable alternative for physicians to assess patient prognosis.
Diseases, Free Full-Text
Data collections - WHO
Diseases, Free Full-Text
Frontiers Serum/plasma biomarkers and the progression of cardiometabolic multimorbidity: a systematic review and meta-analysis
Diseases, Free Full-Text
Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases - ScienceDirect
Diseases, Free Full-Text
The American Journal of Pathology
Diseases, Free Full-Text
Systematic genetic analysis of the MHC region reveals mechanistic underpinnings of HLA type associations with disease
Diseases, Free Full-Text
Prevalence of access to treatment of chronic diseases in Brazil and
Diseases, Free Full-Text
ESC Guidelines on Cardiovascular Diseases during Pregnancy (Management of)
Diseases, Free Full-Text
Annals of Family Medicine
Diseases, Free Full-Text
Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966, Orphanet Journal of Rare Diseases
Diseases, Free Full-Text
COVID-19 Update: Bone Marrow Failure and Infectious Diseases
Diseases, Free Full-Text
Management of Huanglongbing (HLB) by an Intensive Vector and Disease Control in the Surroundings of the Orchard, in Addition to Planting HLB-Free Trees in Okinawa, Japan
Diseases, Free Full-Text
Diffuse Cystic Lung Diseases

© 2014-2024 hellastax.gr. All rights reserved.